Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $19,712 - $22,359
300 New
300 $20,000
Q2 2022

Aug 11, 2022

SELL
$72.62 - $79.98 $347,268 - $382,464
-4,782 Reduced 17.39%
22,715 $1.75 Billion
Q1 2022

Apr 11, 2022

SELL
$61.48 - $73.72 $30,924 - $37,081
-503 Reduced 1.8%
27,497 $2.01 Million
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $35,663 - $41,575
665 Added 2.43%
28,000 $1.75 Million
Q3 2021

Oct 21, 2021

BUY
$59.17 - $69.31 $29,880 - $35,001
505 Added 1.88%
27,335 $1.62 Billion
Q2 2021

Aug 04, 2021

SELL
$61.91 - $67.42 $1,547 - $1,685
-25 Reduced 0.09%
26,830 $1.79 Million
Q1 2021

Apr 23, 2021

BUY
$59.34 - $66.74 $81,295 - $91,433
1,370 Added 5.38%
26,855 $1.7 Million
Q4 2020

Jan 21, 2021

SELL
$57.74 - $65.43 $577 - $654
-10 Reduced 0.04%
25,485 $1.58 Billion
Q3 2020

Oct 14, 2020

BUY
$57.43 - $63.64 $1,435 - $1,591
25 Added 0.1%
25,495 $1.54 Billion
Q2 2020

Jul 15, 2020

SELL
$54.82 - $64.09 $41,937 - $49,028
-765 Reduced 2.92%
25,470 $1.5 Billion
Q1 2020

Apr 21, 2020

BUY
$46.4 - $67.43 $1,160 - $1,685
25 Added 0.1%
26,235 $1.46 Billion
Q4 2019

Jan 22, 2020

SELL
$49.21 - $64.19 $61,266 - $79,916
-1,245 Reduced 4.53%
26,210 $1.68 Billion
Q3 2019

Oct 22, 2019

BUY
$42.77 - $50.71 $40,845 - $48,428
955 Added 3.6%
27,455 $1.39 Billion
Q2 2019

Jul 18, 2019

BUY
$44.62 - $49.34 $179,149 - $198,100
4,015 Added 17.86%
26,500 $1.2 Billion
Q1 2019

Apr 15, 2019

BUY
$45.12 - $53.8 $309,072 - $368,530
6,850 Added 43.81%
22,485 $1.07 Billion
Q4 2018

Jan 25, 2019

BUY
$48.76 - $63.23 $713,602 - $925,371
14,635 Added 1463.5%
15,635 $813 Million
Q2 2018

Jul 31, 2018

BUY
$50.53 - $62.98 $50,530 - $62,980
1,000 New
1,000 $55.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cascade Investment Advisors, Inc. Portfolio

Follow Cascade Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cascade Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cascade Investment Advisors, Inc. with notifications on news.